Rheumatoid Arthritis Increases the Risk of Nontuberculosis Mycobacterial Disease and Active Pulmonary Tuberculosis

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2014 Oct 23

PMID 25337995

Citations 16

Authors

Jun-Jun Yeh

Yu-Chiao Wang

Fung-Chang Sung

Chia-Hung Kao

Affiliations

Soon will be listed here.

Abstract

Background: Few studies have examined the association of rheumatoid arthritis (RA) with nontuberculosis mycobacterium (NTM) disease and pulmonary tuberculosis (PTB).

Methods: We identified 29 131 patients with RA from the catastrophic illness registry who were diagnosed from 1998-2008; 116 524 patients without RA from inpatient data files were randomly frequency matched according to sex, age, and index year and used as a comparison group. Both groups were followed-up until the end of 2010 to measure the incidence of NTM disease and active PTB. We analyzed the risk of NTM disease and active PTB using the Cox proportional hazards regression models, controlling for sex, age, and Charlson comorbidity index (CCI).

Results: The incidence of NTM disease was 4.22 times greater in the RA group than in the non-RA group (1.91 vs 0.45 per 10,000 person-years). The incidence of PTB was 2.99 times greater in the RA group than in the non-RA group (25.3 vs 8.46 per 10,000 person-years). After adjusting for age, sex, and CCI, the adjusted hazard ratios (HRs) of NTM disease and active PTB for the RA group were 4.17 (95% CI = 2.61-6.65) and 2.87 (95% CI = 2.55-3.23), respectively, compared with the non-RA group. In the first 2 years of follow-up, the RA group yielded corresponding adjusted HRs of 4.98 and 3.39 compared with the non-RA group. The follow-up time-specific RA group to the non-RA group HR of both the NTM disease and active PTB varied.

Conclusion: This study can serve as a reference for clinical physicians to increase awareness regarding the detection of NTM disease and active PTB in RA patients among the any stage of the clinical course even without CCI.

Citing Articles

Drug-drug interactions in the management of non-tuberculous mycobacterial infections.

Takeda K, Takazono T, Mukae H Front Microbiol. 2024; 15:1468383.

PMID: 39301186 PMC: 11410596. DOI: 10.3389/fmicb.2024.1468383.

Clinical course of nontuberculous mycobacterial pulmonary disease in patients with rheumatoid arthritis.

Kwak N, Moon J, Kim J, Park J, Yim J Adv Rheumatol. 2024; 64(1):20.

PMID: 38491558 DOI: 10.1186/s42358-024-00357-z.

Association of Tumor Necrosis Factor Inhibitors with the Risk of Nontuberculous Mycobacterial Infection in Patients with Rheumatoid Arthritis: A Nationwide Cohort Study.

Park H, Choi B, Song Y, Oh Y, Lee E, Kim I J Clin Med. 2023; 12(22).

PMID: 38002613 PMC: 10671978. DOI: 10.3390/jcm12226998.

Modulating macrophage function to reinforce host innate resistance against complex infection.

Park H, Lee W, Choi S, Jung M, Shin M, Shin S Front Immunol. 2022; 13:931876.

PMID: 36505429 PMC: 9730288. DOI: 10.3389/fimmu.2022.931876.

Clinical outcomes and prognostic factors of bronchiectasis rheumatoid overlap syndrome: A multi-institution cohort study.

Lin H, Huang H, Lin C, Fang Y, Lin C, Huang Y Front Med (Lausanne). 2022; 9:1004550.

PMID: 36314020 PMC: 9606566. DOI: 10.3389/fmed.2022.1004550.

References

Chan E, Iseman M . Slender, older women appear to be more susceptible to nontuberculous mycobacterial lung disease. Gend Med. 2010; 7(1):5-18. DOI: 10.1016/j.genm.2010.01.005. View

Seve P, Broussolle C, Pavic M . [Primary immunodeficiencies presenting with autoimmune cytopenias in adults]. Rev Med Interne. 2012; 34(3):148-53. DOI: 10.1016/j.revmed.2012.05.007. View

Menzies D, Nahid P . Update in tuberculosis and nontuberculous mycobacterial disease 2012. Am J Respir Crit Care Med. 2013; 188(8):923-7. DOI: 10.1164/rccm.201304-0687UP. View

Winthrop K, McNelley E, Kendall B, Marshall-Olson A, Morris C, Cassidy M . Pulmonary nontuberculous mycobacterial disease prevalence and clinical features: an emerging public health disease. Am J Respir Crit Care Med. 2010; 182(7):977-82. DOI: 10.1164/rccm.201003-0503OC. View

Sleasman J . The association between immunodeficiency and the development of autoimmune disease. Adv Dent Res. 1996; 10(1):57-61. DOI: 10.1177/08959374960100011101. View

Notarangelo L, Casanova J, Conley M, Chapel H, Fischer A, Puck J . Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee Meeting in Budapest, 2005. J Allergy Clin Immunol. 2006; 117(4):883-96. DOI: 10.1016/j.jaci.2005.12.1347. View

Yeh J, Neoh C, Chen C, Chou C, Wu M . A high resolution computer tomography scoring system to predict culture-positive pulmonary tuberculosis in the emergency department. PLoS One. 2014; 9(4):e93847. PMC: 3984117. DOI: 10.1371/journal.pone.0093847. View

Charlson M, Szatrowski T, Peterson J, Gold J . Validation of a combined comorbidity index. J Clin Epidemiol. 1994; 47(11):1245-51. DOI: 10.1016/0895-4356(94)90129-5. View

Chen Y, Chang J, Huang W, Kuo S, Yeh J, Lee J . Molecular epidemiology of Mycobacterium tuberculosis in aboriginal peoples of Taiwan, 2006-2011. J Infect. 2013; 68(4):332-7. DOI: 10.1016/j.jinf.2013.12.004. View

10.

Harboe E, Damas J, Omdal R, Froland S, Sjursen H . [Risk of infection through use of selective immunomodulating drugs for rheumatoid arthritis]. Tidsskr Nor Laegeforen. 2012; 132(16):1867-71. DOI: 10.4045/tidsskr.12.0180. View

11.

Tiippana-Kinnunen T, Kautiainen H, Paimela L, Leirisalo-Repo M . Co-morbidities in Finnish patients with rheumatoid arthritis: 15-year follow-up. Scand J Rheumatol. 2013; 42(6):451-6. DOI: 10.3109/03009742.2013.790073. View

12.

Hsia E, Cush J, Matteson E, Beutler A, Doyle M, Hsu B . Comprehensive tuberculosis screening program in patients with inflammatory arthritides treated with golimumab, a human anti-tumor necrosis factor antibody, in Phase III clinical trials. Arthritis Care Res (Hoboken). 2012; 65(2):309-13. DOI: 10.1002/acr.21788. View

13.

Mori S, Tokuda H, Sakai F, Johkoh T, Mimori A, Nishimoto N . Radiological features and therapeutic responses of pulmonary nontuberculous mycobacterial disease in rheumatoid arthritis patients receiving biological agents: a retrospective multicenter study in Japan. Mod Rheumatol. 2011; 22(5):727-37. PMC: 3440561. DOI: 10.1007/s10165-011-0577-6. View

14.

Yeh J, Wang Y, Lin C, Chou C, Yeh T, Wu B . Nontuberculous mycobacterial infection is associated with increased respiratory failure: a nationwide cohort study. PLoS One. 2014; 9(6):e99260. PMC: 4053398. DOI: 10.1371/journal.pone.0099260. View

15.

. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. This official statement of the American Thoracic Society was approved by the Board of Directors, March 1997. Medical Section of the American Lung Association. Am J Respir Crit Care Med. 1997; 156(2 Pt 2):S1-25. DOI: 10.1164/ajrccm.156.2.atsstatement. View

16.

Winthrop K, Iseman M . Bedfellows: mycobacteria and rheumatoid arthritis in the era of biologic therapy. Nat Rev Rheumatol. 2013; 9(9):524-31. DOI: 10.1038/nrrheum.2013.82. View

17.

Griffith D, Aksamit T, Brown-Elliott B, Catanzaro A, Daley C, Gordin F . An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007; 175(4):367-416. DOI: 10.1164/rccm.200604-571ST. View

18.

Newton S, Mackie S, Martineau A, Wilkinson K, Kampmann B, Fisher C . Reduction of chemokine secretion in response to mycobacteria in infliximab-treated patients. Clin Vaccine Immunol. 2007; 15(3):506-12. PMC: 2268261. DOI: 10.1128/CVI.00401-07. View

19.

Crowson C, Hoganson D, Fitz-Gibbon P, Matteson E . Development and validation of a risk score for serious infection in patients with rheumatoid arthritis. Arthritis Rheum. 2012; 64(9):2847-55. PMC: 3424339. DOI: 10.1002/art.34530. View

20.

Erbes R, Oettel K, Raffenberg M, Mauch H, Schmidt-Ioanas M, Lode H . Characteristics and outcome of patients with active pulmonary tuberculosis requiring intensive care. Eur Respir J. 2006; 27(6):1223-8. DOI: 10.1183/09031936.06.00088105. View